Derek Hicks has sold NTLA and made no open-market buys since Jan 2023
EVP and Chief Business Officer at Intellia Therapeutics, Inc.
SEC CIK 0001901282 · Filings on SEC.gov ↗
$0Bought
$182KSold
NoneLast buy
Every filing
2 filings since Jan 2023, newest first
Filings come from SEC EDGAR. Not investment advice.